Analgesic Effect of Ultrasound Guided Maxillary Nerve Block in Trigeminal Neuralgia
- Conditions
- Trigeminal Neuralgia
- Interventions
- Procedure: US guided block of maxillary nerve
- Registration Number
- NCT06129071
- Lead Sponsor
- Varazdin General Hospital
- Brief Summary
This is a study about the dynamics and effects of ultrasound guided maxillary nerve block in trigeminal neuralgia
- Detailed Description
Standard pharmacological treatment for trigeminal neuralgia is often insufficient. In this setting, patients often suffer trough everyday activities and quality of life is disturbed substantially.
In this prospective clinical study, analgesic effect of ultrasound (US) guided maxillary nerve block will be investigated, in order to prolong pain-free time, reduce the use of standard analgesics, as well as atypical ones (e.g. antiepileptic drugs and antidepressants).
Characteristics of US guided maxillary nerve block will pain investigated: reduction of pain (decrease of VAS score), duration of pain-free period, pain level during the procedure.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- patients with trigeminal neuralgia
- allergy to local anesthetics
- local infection at the site of needle puncture
- parotitis
- serious liver disease
- use of antiarrhythmics group III (eg amiodarone)
- anticoagulant or antithrombotic drugs
- lactation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description US block of maxillar nerve US guided block of maxillary nerve Extraoral ultrasound-guided block of the maxillary nerve will be performed using an ultrasound device. After visualisation of the pterygomandibular space, of the maxillary artery and the mandibular nerve next to it, at a depth of 2-4 cm, the detection of the maxillary artery is confirmed by Color Doppler. A needle enters between the coronoid and condylar processes, using the "out of plane" technique, near the maxillary artery, and after negative aspiration, local anesthetic levobupivacaine (0,5%, 2 mL) combined with triamcinolonacetonid (2mL).
- Primary Outcome Measures
Name Time Method Time without pain 26 weeks Patients will report to the investigator when pain starts to rise - and the amount of time form the procedure to the reporting will be recorded
- Secondary Outcome Measures
Name Time Method Trend of pain level Pain level at three time points: 1 month, 3 months and 6 months after the procedure Pain will be graded according to visual analogue scale, 0 meaning no pain, 10 meaning the worse pain possible
Time to sart of the action of the block Immediately after the procedure Time from the procedure till the pain is reduced, in minutes
Pain level when anesthesia is applied Immediately after the procedure Pain will be graded according to visual analogue scale, 0 meaning no pain, 10 meaning the worse pain possible
Trial Locations
- Locations (1)
Varazdin General Hospital
🇭🇷Varaždin, Croatia